Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 91074
MIM: 610856
HGNC: 17234
Ensembl: ENSG00000148513
Variants:
dbSNP: 91074
ClinVar: 91074
TCGA: ENSG00000148513
COSMIC: ANKRD30A
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000148513 | ENST00000361713 | R4GNA2 |
| ENSG00000148513 | ENST00000374660 | Q5W026 |
| ENSG00000148513 | ENST00000602533 | R4GNA2 |
| ENSG00000148513 | ENST00000611781 | Q9BXX3 |
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 31786890 | 2019 | A four-gene expression-based signature predicts the clinical outcome of melanoma. | 3 |
| 31786890 | 2019 | A four-gene expression-based signature predicts the clinical outcome of melanoma. | 3 |
| 29116378 | 2018 | Preferential expression of NY-BR-1 and GATA-3 in male breast cancer. | 0 |
| 29116378 | 2018 | Preferential expression of NY-BR-1 and GATA-3 in male breast cancer. | 0 |
| 27863482 | 2016 | In silico SNP analysis of the breast cancer antigen NY-BR-1. | 2 |
| 27863482 | 2016 | In silico SNP analysis of the breast cancer antigen NY-BR-1. | 2 |
| 26415367 | 2015 | NY-BR-1 Antigen Expression and anti-NY-BR-1 IgG in Egyptian Breast Cancer Patients: Clinicopathological and Prognostic Significance. | 0 |
| 26415367 | 2015 | NY-BR-1 Antigen Expression and anti-NY-BR-1 IgG in Egyptian Breast Cancer Patients: Clinicopathological and Prognostic Significance. | 0 |
| 23731661 | 2013 | Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications. | 22 |
| 23731661 | 2013 | Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications. | 22 |
| 18041742 | 2008 | Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. | 7 |
| 18041742 | 2008 | Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. | 7 |
| 17330232 | 2007 | The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer. | 12 |
| 17536312 | 2007 | NY-BR-1 is a differentiation antigen of the mammary gland. | 11 |
| 17330232 | 2007 | The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer. | 12 |
Citation
Dessen P
ANKRD30A (ankyrin repeat domain 30A)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/41596/ankrd30a
